A trial is set for a bizarre antitrust case surrounding a ban on cloned horses for membership in the American Quarter Horse Association, say reports. Jason Abraham and two of his companies filed a lawsuit against the AQHA in 2012 against the ban, claiming the restrictions violated antitrust law and are anticompetitive for owners of cloned horses. Plaintiffs Abraham & Veneklasen Joint Venture, Abraham Equine Inc. and Gregg Veneklasen claim the cloning ban prevents horses that cannot be registered with the organization from competing with those that are registered; further, the plaintiffs accuse the AQHA of abusing its monopoly to bar market entry. The trial is set for July 16.
Full Content: BioNews
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Regulator Puts Brakes on £762 Million Logistics Merger Amid Competition Fears
Nov 3, 2024 by
CPI
Nvidia’s Acquisition of AI Startup Run.ai Faces EU Antitrust Review
Nov 3, 2024 by
CPI
Voters Across US to Decide on Landmark Gig Economy Issues on November Ballots
Nov 3, 2024 by
CPI
Court Gives Green Light to $110M Deal in Real Estate Commission Dispute
Nov 3, 2024 by
CPI
Mexico’s First-Ever Class Action Targets Pharma Giants for Price Fixing
Nov 3, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI